Stockreport

Sanofi to buy Dynavax for $15.50 per share [Seeking Alpha]

Dynavax Technologies Corporation  (DVAX) 
Last dynavax technologies corporation earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dynavax.com
PDF company at approximately $2.2 billion—a 39% premium to its December 23 closing price. This deal adds Dynavax's marketed HEPLISAV-B adult hepatitis B vaccine and Reco [Read more]